Bristol-Myers Squibb Company Ce (CELG-RI) stock analysis

In our weekly check, Bristol-Myers Squibb Company Ce is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 2, red flags: 5.

About Bristol-Myers Squibb Company Ce

Bristol-Myers Squibb Company Ce is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as CELG-RI.

What our checks show for CELG-RI

Red flags

• The gross margin fell by 9.3 points, to 69.2%: costs are rising faster than prices.
• Analysts expect revenue to shrink about 7.5% a year.
• The price swings a lot: 250% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 88% from a peak. Would you have held through that?
• Thinly traded (about 14 thousand shares a day): buying and selling can move the price.

Warning signs

• Net debt is 2.3x a year of EBITDA (debt/equity 1.91). That limits room in a downturn and raises refinancing risk.
• Revenue grew only 2.7% a year over the last 3 years.

Strengths

• The net margin rose by 3.4 points over 5 years, to 18.5%.
• Analysts expect earnings per share to grow about 10.3% a year over the next years.
• Analysts expect the net margin to improve by 8.9 points from today's 18.5%.
• Earnings per share grew 15% a year over the last 3 years.
• Net profit grew 13.5% a year over the last 3 years.
• Free cash flow is 18.6% of revenue: cash for dividends, buybacks or growth.

Similar companies

SNY · GSK · PFE · NVO · GILD · AMGN

Questions

What grade does Bristol-Myers Squibb Company Ce (CELG-RI) have?

In our weekly check, Bristol-Myers Squibb Company Ce is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 2, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of CELG-RI stock?

This week's biggest flags for Bristol-Myers Squibb Company Ce: Gross margin falling, Weak revenue forecast, Very volatile. In total 7 of 25 checks show a warning or a red flag.

What does Bristol-Myers Squibb Company Ce do?

Bristol-Myers Squibb Company Ce is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as CELG-RI.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-07

Open the full analysis